Pictet & Cie (Europe) Sa 10x Genomics, Inc. Transaction History

Pictet & Cie (Europe) Sa

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$34.32 - $57.55 $7,996 - $13,409	-233 Reduced 3.66%	6,138 $343,000
Q3 2023 Nov 02, 2023	SELL	$40.86 - $62.98 $3,759 - $5,794	-92 Reduced 1.42%	6,371 $262,000
Q2 2023 Aug 08, 2023	SELL	$50.96 - $58.72 $12,841 - $14,797	-252 Reduced 3.75%	6,463 $360,000
Q4 2022 Feb 08, 2023	BUY	$24.4 - $41.3 $163,846 - $277,329	6,715 New	6,715 $0
Q2 2022 Aug 05, 2022	SELL	$36.95 - $82.41 $156,446 - $348,923	-4,234 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$55.7 - $145.79 $23,839 - $62,398	428 Added 11.25%	4,234 $322,000
Q4 2021 Feb 02, 2022	BUY	$135.05 - $182.59 $63,068 - $85,269	467 Added 13.99%	3,806 $567,000
Q3 2021 Nov 10, 2021	SELL	$145.58 - $192.14 $44,984 - $59,371	-309 Reduced 8.47%	3,339 $486,000
Q2 2021 Aug 11, 2021	BUY	$134.22 - $202.37 $208,846 - $314,887	1,556 Added 74.38%	3,648 $714,000
Q1 2021 May 10, 2021	BUY	$140.25 - $196.86 $293,403 - $411,831	2,092 New	2,092 $379,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.